ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Charlotte, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Charlotte, NC, USA:

Signatera Assessment in Early-Stage Endometrial Cancer (SIGNAL-EMC 101)

The goal of this clinical trial is to assess if circulating tumor DNA can guide adjuvant selection in high-intermediate risk early-stage endometrial...

Begins enrollment in 1 month
Endometrial Cancer
Device: Signatera Genome ultra-sensitive ctDNA blood test
Natera
Natera

Charlotte, North Carolina, United States and 11 other locations

A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...

Enrolling
Endometrial Cancer
Endometrioid Endometrial Cancer
Drug: nab-sirolimus

Phase 2

Aadi Bioscience

Charlotte, North Carolina, United States and 8 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Charlotte, North Carolina, United States and 248 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Charlotte, North Carolina, United States and 168 other locations

Locations recently updated

to Part A (Phase 1a and Phase 1b) will include ovarian and endometrial cancers. Enrollment to Part B (Phase 1a and Phase 1b) will i...

Enrolling
Endometrial Cancer
Platinum Resistant Ovarian Cancer
Drug: HWK-016, MUCIN-16-targeted ADC
Drug: Bevacizumab

Phase 1

Whitehawk Therapeutics, Inc.

Charlotte, North Carolina, United States and 11 other locations

antitumor activity of IMGN151 in adult participants with recurrent endometrial cancer; recurrent, high-grade serous epithelial ovar...

Active, not recruiting
Endometrial Cancer
Fallopian Tube Cancer
Drug: IMGN151

Phase 1

AbbVie
AbbVie

Charlotte, North Carolina, United States and 57 other locations

A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients wit...

Enrolling
Non Small Cell Lung Cancer
Ovarian Cancer
Drug: DR-0202

Phase 1

Dren Bio

Huntersville, North Carolina, United States and 9 other locations

This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor ac...

Enrolling
Solid Tumor
Endometrial Cancer
Drug: Fulvestrant injection
Drug: TER-2013

Phase 1, Phase 2

Terremoto Biosciences Inc.

Huntersville, North Carolina, United States of America and 14 other locations

in participants with select loco-regionally recurrent solid tumors or metastatic solid tumors where curative or standard treatment ...

Active, not recruiting
Neoplasms
Drug: GSK5764227
Drug: Dostarlimab

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Charlotte, North Carolina, United States and 25 other locations

Locations recently updated

find the best dose of study drug in people who have advanced solid tumor cancers.In Part 2, participants will receive the best dose...

Enrolling
Ovarian Neoplasms
Prostatic Neoplasms
Drug: DM002

Phase 1, Phase 2

Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Huntersville, North Carolina, United States of America and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems